MONTREAL, Feb. 18, 2026 (GLOBE NEWSWIRE) — Knight Therapeutics Inc., (TSX: GUD) (“Knight”) a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltda., has submitted a marketing authorization application to ANVISA, the Brazilian health regulatory agency, for NIKTIMVO® (axatilimab) for the treatment of chronic graft-versus-host disease (GVHD) after failure of at least two prior lines of systemic therapy in adult and pediatric patients 6 years and older. Advertisement On August 4, 2025, Knight announced that it expanded its existing relationship and amended its agreement with Incyte for the exclusive rights to distribute retifanlimab (commercialized as ZYNYZ® (retifanlimab) in the United States and Europe) and axatilimab (commercialized as NIKTIMVO® (axatilimab-csfr) in the United States) in Latin America. Under the terms of the amended agreement, Incyte will be responsible for the development, manufacture and supply to Knight of retifanlimab and axatilimab, and Knight will be responsible for seeking the necessary regulatory approvals and distributing both medicines in Latin America. Knight and Incyte had entered into an exclusive supply and distribution agreement for tafasitamab (commercialized as MONJUVI® (tafasitamab-cxix) in the United States) and pemigatinib (commercialized as PEMAZYRE® in the United States) in Latin America in September 2021. NIKTIMVO® received approval from the U.S. Food and Drug Administration in August 2024 for the treatment of chronic GVHD after failure of at least two prior lines of systemic therapy in adult and pediatric patients weighing at least 40 kg. 1 “For patients living with chronic graft-versus-host disease, every new treatment option can mean hope for a better quality of life’, said Samira Sakhia, President and Chief Executive Officer, Knight Therapeutics Inc. “The submission of axatilimab in Brazil brings us closer to making that hope a reality. At Knight, our mission goes beyond expanding our portfolio-we are committed to ensuring that patients and their families have access to therapies that truly make a difference. This milestone reflects the strength of our partnership with Incyte and our shared dedication to improving lives across Latin America.’ About Chronic Graft-Versus-Host Disease (GVHD) Get the latest news delivered to your inbox Sign up for The Manila Times newsletters By signing up with an email address, I acknowledge that I have read and agree to the Terms of Service and Privacy Policy Chronic GVHD is a serious complication of allogeneic stem cell transplantation in which the donor’s immune cells attack the recipient’s tissues, often occurring during the first-year post-transplant.2 Chronic GVHD involves features of autoimmunity and immunodeficiency, multiple organs (such as the skin, liver, lungs, and gastrointestinal tract), irreversible fibrotic manifestations, and systemic toxicities complicated by the use of immunosuppressants which all contribute to devastating health consequences such as mortality, morbidity, and decreased quality of life in patients.3 There are approximately 1400 – 1800 reported allogeneic transplants in Brazil every year.4 Chronic GVHD is the most common late complication after allogeneic hematopoietic cell transplantation affecting 30%-70% of recipients, globally.3 Based on a recent analysis by the Brazilian National hematopoietic stem cell transplantation (HSCT) Registry, in collaboration with Brazilian Society of Cellular Therapy and Bone Marrow Transplantation (SBTMO), Center for International Blood and Marrow Transplant Research (CIBMTR), and Hematopoietic Cell Transplantation Brazilian Registry (HCTBR), the 2-year cumulative incidence chronic GVHD was determined to be 29.5%.5 About NIKTIMVO® (axatilimab) Advertisement NIKTIMVO® (axatilimab) is a first-in-class colony stimulating factor-1 receptor (CSF-1R)-blocking antibody approved for use in the U.S. for the treatment of chronic graft-versus-host disease (GVHD) after failure of at least two prior lines of systemic therapy in adult and pediatric patients weighing at least 40 kg .1 The efficacy and safety for this indication were evaluated in the
Tag: “consensus”
-
First Coast Connect: Federal rollback of a key Clean Air Act rule (Video)
First Coast Connect: Federal rollback of a key Clean Air Act rule (Video)
NOW
The federal rollback of a key Clean Air Act rule puts the United States in conflict with international scientific consensus and public health priorities. Late last week, the Trump administration snuffed out pollution limits on planet-warming greenhouse gases, including emissions from tailpipes and power plants. The Trump administration calls it the …
Read further at news source
★ FURTHER REFERENCES ★
★ RELATED STORIES
IN FLORIDA ★ -
EU Officials Hold ‘Constructive’ Meeting To Strengthen International Role Of Euro
ISTANBUL, Feb 17 (Bernama-Anadolu) — European Union (EU) leaders held “constructive” initial discussions Monday on renewed efforts to strengthen the international role of the euro, EU Commissioner for Economy Valdis Dombrovskis announced, Anadolu Ajansi reported.
Dombrovskis said at the Eurogroup press conference in Brussels that the increasingly complex geopolitical environment provides a new impetus for action on this issue
“A greater international role for the euro can be an important cornerstone of our de-risking strategy and help to ensure economic and financial stability and security,” he said.
At the same time, Dombrovskis said, it can boost the EU’s competitiveness, for instance, by lowering borrowing costs and shielding EU importers and exporters from exchange rate fluctuations.
Dombrovskis explained that at the meeting, he presented finance ministers with a comprehensive set of possible actions regarding the global role of the euro, stating that its global appeal would be determined, above all, by the strength and resilience of the European economy.
He noted that within the EU, they need to implement the Savings and Investment Union, finalise the digital euro proposal, diversify their trade network, and improve their defence capabilities.
Pointing out that widespread use of the euro would contribute to these efforts, he said: “I would say that there was a broad consensus from ministers on working on the international role of the euro.”
He also said they discussed possible additional actions reflecting new challenges, adding, “There is a need to make EU retail payment systems more autonomous, building around the digital euro’s infrastructure and wide acceptance network, and to enhance the issuance of euro-denominated digital assets.”
— BERNAMA-ANADOLU -
Litigators Urged to Challenge Potentially Inquorate Agencies
For the past year, several federal multimember regulatory agencies have been operating with a fraction of their seats filled. Though a single absence doesn’t impede a commission’s ability to operate, too many losses could render an agency inquorate and legally unable to act. Thanks to term expirations, resignations, and presidential removal, agencies with significant vacancies include the Commodity Futures Trading Commission, which has one of five seats filled; the Federal Trade Commission, which has two of five filled; and the National Credit Union Administration, which has one of three filled. Despite these vacancies, the agencies continue to act. Supporters argue that the absence of explicit, statutory quorum requirements allows any remaining officials to act—even when, in the case of the NCUA, the agency’s regulations provide that ‘agreement of at least two of the three Board members is required for any action by the Board.’ We question these assertions and encourage litigators already challenging these agencies’ actions to include quorum violations among their claims that the agencies acted unlawfully. The Common Law of Quorums. For centuries, courts have been called upon to evaluate the authority possessed by multimember institutions plagued by vacancies. Over time, they developed default rules that apply in the absence of statutory requirements: First, a simple majority of members constitutes a quorum. Second, this majority is based on the total number of positions, including vacant seats; we call this a fixed-numerosity quorum, in contrast with an appointed-majority quorum that excludes vacancies. Third, bodies may enact quorum rules only if the legislature or their chartering document has granted them explicit authority to do. The first two rules balance the risks of decisional errors against the risks of dysfunction. Without a majority-quorum rule, a minority of members may exercise the body’s authority in ways that distort collective decision-making and undermine the intent that the body operates through a deliberative process. Requiring the participation of all members, however, prevents the body from functioning when there are absences due to illness or vacancy. The third rule prohibits institutions from enacting their own rules that defeat the goals of deliberation and collective decision-making. Quorums and Federal Agencies. The US Supreme Court has endorsed compliance with these common law rules when statutory quorum requirements are absent or ambiguous, though it has never opined on whether these rules must or may not be followed. In FTC v. Flotill Products, Inc., the court explained that the FTC was ‘justified in adhering to [the] common-law rule’ that ‘a majority of a quorum constituted of a simple majority of collective body is empowered to act for the body.’ However, lower courts have diverged from these rules. Contrary to the third common law default above, the US Court of Appeals for the DC Circuit explained in Falcon Trading Group., Ltd. v. Securities and Exchange Commission that, ‘[i]f not otherwise constrained by statute, an agency sufficiently empowered by its enabling legislation may create its own quorum rule.’ Relatedly, the US Court of Appeals for the Seventh Circuit in Assure Competitive Transportation, Inc. v. United States rejected the common law’s fixed numerosity rule, holding instead that ‘a majority of the Commissioners actually in office constitutes a quorum.’ The US Court of Appeals for the Tenth Circuit concurred in Union Pacific Railroad Company v. United States. Applying the common law default rules to federal multimember agencies is appropriate and consistent with congressional intent. Congress created commissions as multimember rather than single-headed agencies to encourage deliberation and consensus among a set of varied stakeholders. It frequently imposed qualifications on commissions’ members so that certain viewpoints would be represented, including partisan balance, geographic representation,
-
Why Do Gamers Invert Their Controls?
In terms of sheer numbers, inverters vs. non-inverters is the biggest schism in the games community. Whenever the subject comes up, it always leads to some petty argument about how you tilt your head when you look around in real life vs. “No, up means up, you loser, your head is not a tiny aeroplane.” Look, maybe my head is a tiny aeroplane, and my brain is the pilot. And that’s before we get to the fact that inverters are at a massive disadvantage in these matters because ‘invert’ rhymes with ‘pervert’. For one of these groups, it is merely a fact of life: whether nature or nurture, to those of us afflicted with the scourge of invertism – a stigma I have lived with for most of my life – pushing forward on a stick to look down comes just as naturally as walking or breathing. There’s a lot of misconceptions about inverters, perpetuated by people on either side of the divide. That people who invert are outliers, that it’s some kind of “skill issue”, that it doesn’t make sense to invert Y if you aren’t also going to invert X. That it’s easy to switch with a bit of practice. That it all depends on what your first game system was. But, according to researchers Jennifer Corbett and Jaap Munneke, who surveyed a big sample of gamers and subjected them to cognitive 3D spatial awareness testing, whether or not you played flight simulators as a child has absolutely no bearing whatsoever on your Y-axis praxis. Though this study has gone some way to disproving these commonly held myths, it stops short of providing any real answers about why some people invert, and why others do not. Largely, I suspect, because that’s rather like trying to explain the briefs or boxers divide. There’s an unknowable number of factors to consider re: why someone would have a preference, and it doesn’t matter anyway because… well, it’s just underwear. It only matters to the individual concerned. It’s not like one day they’re going to stop making boxers. Flight sims are one of the only times a non-inverted player may choose to invert Y. Except, as the study sort of says if you actually read it, it’s not just a personal preference. Well, it is, but it’s one that’s massively dictated by how your brain happens to be wired and how it handles spatial awareness. Although with practice and perseverance, some people have found that they can unlearn their default and switch over – usually this is from inverting to not inverting – it’s kind of half-way between a personal preference and an accessibility issue. It’s a bit of both. And understanding it may well be crucial for important things beyond the realm of gaming, such as telesurgery or drone operation. All kinds of applications where the operator’s spatial awareness is being distorted by a non-standard field of view, the lack of a third dimension, input lag, frame drops, and more besides. I dunno. I’m guessing. I’m not trying to get a research grant, so I’m not that invested in whether or not that’s a convincing pitch for how serious this issue is. What’s incredible about the study’s findings is that, and I’m quoting the researchers from an article in The Guardian here, ‘None of the reasons people gave us [for inverting controls] had anything to do with whether they actually inverted’. So, all of us are barking down the wrong tree, and it actually has more to do with how you process 3D space at a deep cognitive level. This absolutely
-
Kepler Cheuvreux cuts Interpump Group to ‘hold,’ slashes PT on weak 2026 outlook
Investing.com — Kepler Cheuvreux in a note dated Monday downgraded Interpump Group (BIT:ITPG) to ‘hold’ from ‘buy’ and cut its target price to €45 from €52, citing disappointing 2026 guidance that points to a year of minimal growth for the Italian capital goods manufacturer. The investment bank reduced its fiscal 2026 earnings per share estimate by 9.9% and its EBITDA forecast by 6.7% to €475 million from €509 million following the company’s results announcement. Stay ahead with live news, stock impact insights, and Wall Street analysis – save up to 50% The new target price implies a price-to-earnings ratio of 21 times for 2026, compared to the current 19 times, which Kepler Cheuvreux analyst Matteo Bonizzoni described as “more than adequate given that 2026, as said, is going to be substantially ex-growth.” Interpump posted fiscal 2025 EBITDA of €462 million, missing Kepler Cheuvreux’s estimate of €471 million and consensus expectations of €470 million. The EBITDA margin came in at 22.3%, within the company’s guidance range of 22-22.5% but 40 basis points below Kepler Cheuvreux’s forecast of 22.7% and 30 basis points below consensus of 22.6%. The fourth-quarter results drove the miss, with EBITDA falling 8.4% short of estimates, the report said. The hydraulics division accounted for nearly the entire shortfall, with EBITDA 13.2% below Kepler Cheuvreux’s expectations, while water jetting missed by just 1.4%. The hydraulics division’s EBITDA margin in the fourth quarter was 16.7%, 220 basis points below the estimate of 18.9% and 390 basis points lower than the nine-month 2025 figure. Management blamed production inefficiencies for the weak fourth-quarter hydraulics performance but did not cite any specific one-off items, according to the report. This contrasted with the fourth quarter of 2024, when management attributed poor results to an inventory write-down with an impact of approximately €8 million. The company’s 2026 guidance proved more disappointing than the 2025 results. Management expects organic growth of negative 2% to positive 3% for fiscal 2026, well below Kepler Cheuvreux’s prior estimate of 5.8% and consensus of approximately 5%, the report said. “Guidance miss driven by Water Jetting, which is expected to decline,” Bonizzoni said, noting that management expects recovery in hydraulics to continue but anticipates weakness in water jetting, particularly in the first half of 2026 due to difficult year-over-year comparisons. Water jetting is characterized as a late-cyclical business in the report. Organic growth in the fourth quarter of 2025 was 1.7%, slowing from 2.3% in the third quarter and below Kepler Cheuvreux’s estimate of 3.8%, according to the data provided. Hydraulics posted 4.8% organic growth, accelerating from 3.4% in the third quarter, while water jetting declined 1.8%, compared to 0.2% growth in the third quarter. Net financial debt excluding put options stood at €291 million, in line with Kepler Cheuvreux’s estimate of €290 million. Free cash flow for fiscal 2025 was €220 million, slightly below the estimate of €226 million and representing 4.9% of market capitalization, the report said. Interpump’s market capitalization stood at €4.5 billion as of Feb. 13, with shares trading at €41.50, according to the report. The stock has declined 11.3% year-to-date. For 2028, management outlined ambitions including sales of €2.5 billion, compared to Kepler Cheuvreux’s estimate of €2.3 billion at current perimeter, and an EBITDA margin of 22.5%, including some dilutive impact from mergers and acquisitions, versus Kepler Cheuvreux’s forecast of 23.3%. The company targets zero net financial position by 2028, compared to Kepler Cheuvreux’s projection of €316 million in net cash. Kepler Cheuvreux revised its fiscal 2027 EPS estimate down 8.6% as part of the forecast adjustments. Should you be buying ITPG right now? ProPicks AI
-
BASF Strengthens Business Services Through Global Hub Setup
Key Takeaways
Under the strategy, key Finance and Human Resources functions will be consolidated at the new India hub, while supply chain activities will be optimized through BASF’s existing center in Kuala Lumpur, Malaysia. Meanwhile, services that depend on proximity to customers or local operations will remain regionally managed to ensure agility and timely support.
Management noted that the hub model will help simplify processes, increase automation and leverage competitive operating costs, enabling a more flexible and scalable service platform that supports BASF’s long-term strategic priorities.
This expansion complements BASF’s existing Global Business Services footprint in Berlin, Kuala Lumpur and Montevideo. Global Business Services employs roughly 8,500 people and provides services across areas, including Finance, Logistics, HR, Communications, Regulatory & IP, and Environment, Health, Safety & Quality.
Shares of BASFY are up 19.6% over the past year against the industry’s fall of 10.9%
Image Source: Zacks Investment ResearchBASFY’s Zacks Rank & Key Picks
Better-ranked stocks in the Basic Materials space include Albemarle Corporation (ALB Quick QuoteALB – Free Report) , Air Products and Chemicals, Inc. (APD Quick QuoteAPD – Free Report) and Methanex Corporation (MEOH Quick QuoteMEOH – Free Report) . ALB sports a Zacks Rank of #1 (Strong Buy), while APD and MEOH carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for ALB’s current-year loss is pegged at 70 cents per share, indicating a 70.1% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with the average earnings surprise of 35.3%.
The Zacks Consensus Estimate for APD’s current fiscal-year earnings stands at $13.01 per share, reflecting a 8.15% year-over-year increase. Its earnings beat the Zacks Consensus Estimates in two of the trailing four quarters and missed twice, with the average earnings surprise of 0.44%.
The Zacks Consensus Estimate for MEOH’s current fiscal-year earnings is pegged at $3.17 per share, indicating a 15% year-over-year decline. Its earnings beat the Zacks Consensus Estimates in three of the trailing four quarters and missed once, with the average earnings surprise of 17.4%.
5 Stocks Set to Double Each was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They include Stock #1: A Disruptive Force with Notable Growth and Resilience Stock #2: Bullish Signs Signaling to Buy the Dip Stock #3: One of the Most Compelling Investments in the Market Stock #4: Leader In a Red-Hot Industry Poised for Growth Stock #5: Modern Omni-Channel Platform Coiled to Spring Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%.
See Our Newest 5 Stocks Set to Double Picks >> -
POOJA HEGDE OVERRATED? Hell No – Fans ERUPT in Savage Defense
Hold up—someone dared call pooja hegde overrated? In 2026, as the stunning South indian siren continues to dominate screens and red carpets with her unmatched glow, a heated X debate has erupted like wildfire, pitting clueless trolls against a tidal wave of die-hard fans screaming one truth: NOT AT ALL. From viral threads dissecting her “captivating charm” to savage clapbacks declaring she “deserves more hype,” the internet is united in fury against the haters.
Pooja isn’t riding some inflated wave—she’s the real deal: scorching hot, effortlessly beautiful, with a skintone that’s pure magic and an alluring presence that leaves jaws dropped. While detractors whisper “overhyped,” fans roar back: she’s still criminally underrated in a bollywood obsessed with fleeting trends. This isn’t a debate—it’s a demolition of doubters. Buckle up as we savage the myth and crown what’s obvious: pooja hegde is Bollywood’s hidden gem shining brighter than ever. Beauty That Breaks the Internet: Hotter Than Your Wildest Dreams
Let’s start with the obvious—Pooja Hegde is straight fire. Fans flood X screaming, “She is so hot, beautiful, and her skintone unmatchable & so attractive.” That golden glow? Weaponized perfection. Haters calling her overrated clearly need glasses—her looks alone carry films and steal scenes. Underrated? Absolutely, because no one’s matching that level of natural slayage in today’s filter-obsessed era.
Captivating Charm That Owns Every Room – Still Flying Under the Radar
“She is actually an owner of captivating charm and glow. I think she is still underrated.” Boom—mic drop from the masses. Pooja’s aura isn’t manufactured; it’s magnetic, pulling you in with every smile and strut. From concert sightings to blockbuster roles, she exudes effortless star power. Overrated? Laughable. She’s the charm queen bollywood desperately needs more of, yet somehow gets slept on.
A Resounding “Big NO” From the Fan army – She Deserves the Throne
The debate’s loudest echo? “A Bigg NO” to overrated claims. “She even deserves more hype.” Exactly. Pooja’s delivered hits in telugu and hindi cinema, danced like a goddess, and slayed the fashion game without the constant media circus others get. Fans know: her talent and presence warrant superstar status—not these underrated limbo haters try to box her in.
Glow Game Unrivaled: The Skintone Envy That’s Real
Trolls are mad because Pooja’s radiant skin tone and beauty are unattainable goals? “Her skintone is unmatchable & so attractive”—fans aren’t wrong. In a sea of same-same starlets, her glow stands alone, turning casual concert outings into viral fashion moments. Overrated? Nah, she’s the benchmark others chase while staying humbly underrated.
The Viral Verdict: pooja Wins, Haters Lose – Time for More Hype
This X war isn’t close—overwhelming consensus: Not overrated, not even close. pooja hegde is the total package: beauty, charm, talent, and that elusive “it” factor. Fans demand justice: more roles, more spotlight, more recognition. The debate exposed one truth—calling her overrated is the real delusion. queen pooja reigns supreme; haters, stay pressed. She’s underrated gold waiting to explode. -
Cibc World Market Inc. Has $27.83 Million Holdings in Targa Resources, Inc. $TRGP
Cibc World Market Inc. decreased its holdings in Targa Resources, Inc. (NYSE:TRGP – Free Report) by 3.2% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 166,119 shares of the pipeline company’s stock after selling 5,501 shares during the quarter. Cibc World Market Inc. owned 0.08% of Targa Resources worth $27,832,000 at the end of the most recent reporting period. Get Targa Resources alerts: Sign Up A number of other institutional investors and hedge funds have also recently made changes to their positions in TRGP. Norges Bank bought a new position in shares of Targa Resources during the second quarter worth approximately $708,366,000. Mitsubishi UFJ Trust & Banking Corp increased its stake in Targa Resources by 441.3% during the 2nd quarter. Mitsubishi UFJ Trust & Banking Corp now owns 675,352 shares of the pipeline company’s stock worth $117,565,000 after acquiring an additional 550,591 shares during the period. Franklin Resources Inc. increased its stake in Targa Resources by 306.6% during the 2nd quarter. Franklin Resources Inc. now owns 601,370 shares of the pipeline company’s stock worth $104,686,000 after acquiring an additional 453,460 shares during the period. Vanguard Group Inc. raised its holdings in Targa Resources by 1.4% in the 2nd quarter. Vanguard Group Inc. now owns 27,960,214 shares of the pipeline company’s stock valued at $4,867,314,000 after acquiring an additional 375,939 shares in the last quarter. Finally, Ensign Peak Advisors Inc lifted its position in shares of Targa Resources by 290.5% during the 2nd quarter. Ensign Peak Advisors Inc now owns 503,770 shares of the pipeline company’s stock valued at $87,696,000 after acquiring an additional 374,768 shares during the period. Institutional investors and hedge funds own 92.13% of the company’s stock. Targa Resources Stock Performance Targa Resources stock opened at $222.18 on Thursday. The business has a 50 day moving average of $188.52 and a 200-day moving average of $172.70. The company has a market capitalization of $47.69 billion, a P/E ratio of 29.54, a P/E/G ratio of 0.93 and a beta of 0.88. Targa Resources, Inc. has a 1 year low of $144.14 and a 1 year high of $222.59. The company has a debt-to-equity ratio of 5.91, a current ratio of 0.77 and a quick ratio of 0.61. Targa Resources Announces Dividend The firm also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 30th will be paid a dividend of $1.00 per share. The ex-dividend date of this dividend is Friday, January 30th. This represents a $4.00 annualized dividend and a dividend yield of 1.8%. Targa Resources’s dividend payout ratio (DPR) is presently 53.19%. Insiders Place Their Bets In other news, insider Gerald R. Shrader sold 2,750 shares of Targa Resources stock in a transaction on Friday, December 5th. The shares were sold at an average price of $181.21, for a total transaction of $498,327.50. Following the transaction, the insider owned 29,561 shares in the company, valued at approximately $5,356,748.81. The trade was a 8.51% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider D. Scott Pryor sold 20,000 shares of the stock in a transaction on Friday, November 14th. The shares were sold at an average price of $172.21, for a total value of $3,444,200.00. Following the completion of the sale, the insider owned 22,139 shares of the company’s stock, valued at $3,812,557.19. The trade was a 47.46% decrease in their ownership of the stock.
-
Williams Companies (NYSE:WMB) Given New $78.00 Price Target at Royal Bank Of Canada
Williams Companies (NYSE:WMB – Get Free Report) had its price objective increased by Royal Bank Of Canada from $75.00 to $78.00 in a report issued on Wednesday,Benzinga reports. The brokerage presently has an “outperform” rating on the pipeline company’s stock. Royal Bank Of Canada’s price objective would suggest a potential upside of 9.64% from the company’s previous close. Get Williams Companies alerts: Sign Up Several other brokerages also recently commented on WMB. Mizuho upgraded shares of Williams Companies to a “strong-buy” rating in a report on Monday, October 27th. Zacks Research raised Williams Companies from a “strong sell” rating to a “hold” rating in a research note on Wednesday, February 4th. Tudor Pickering upgraded Williams Companies from a “hold” rating to a “strong-buy” rating in a research report on Monday, December 1st. Citigroup boosted their price target on Williams Companies from $65.00 to $70.00 and gave the company a “buy” rating in a research note on Thursday, November 13th. Finally, Barclays boosted their target price on shares of Williams Companies from $65.00 to $66.00 and gave the stock an “equal weight” rating in a research report on Tuesday, October 14th. Two analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat.com, Williams Companies has an average rating of “Moderate Buy” and an average price target of $70.43. View Our Latest Stock Report on Williams Companies Williams Companies Stock Up 3.3% NYSE WMB traded up $2.30 on Wednesday, reaching $71.14. The stock had a trading volume of 5,747,432 shares, compared to its average volume of 8,127,381. The company has a current ratio of 0.42, a quick ratio of 0.36 and a debt-to-equity ratio of 1.73. Williams Companies has a 1 year low of $51.58 and a 1 year high of $71.58. The business has a 50 day moving average price of $62.16 and a 200 day moving average price of $60.55. The company has a market capitalization of $86.88 billion, a price-to-earnings ratio of 36.70, a P/E/G ratio of 1.57 and a beta of 0.65. Williams Companies (NYSE:WMB – Get Free Report) last announced its earnings results on Tuesday, February 10th. The pipeline company reported $0.55 earnings per share for the quarter, missing the consensus estimate of $0.57 by ($0.02). The business had revenue of $3.20 billion for the quarter, compared to the consensus estimate of $3.10 billion. Williams Companies had a net margin of 20.61% and a return on equity of 16.74%. During the same quarter in the previous year, the company earned $0.47 EPS. Williams Companies has set its FY 2026 guidance at 2.200-2.380 EPS. On average, analysts forecast that Williams Companies will post 2.08 EPS for the current fiscal year. Insider Activity In other Williams Companies news, SVP Terrance Lane Wilson sold 2,000 shares of the business’s stock in a transaction on Monday, February 2nd. The stock was sold at an average price of $66.39, for a total value of $132,780.00. Following the sale, the senior vice president directly owned 293,545 shares of the company’s stock, valued at approximately $19,488,452.55. The trade was a 0.68% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.44% of the stock is currently owned by insiders. Institutional Investors Weigh In On Williams Companies Several large investors have recently made changes to their positions in WMB. Vanguard Group Inc. boosted its stake in Williams Companies by 0.7% during the fourth quarter. Vanguard Group Inc. now